Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

AXGNBSX

AxoGen, Inc.

AXGN · $38.06

60Good

Boston Scientific Corporation

BSX · $45.05

67Good

Area by area

Overall Quant Score

How does it look overall? (out of 100)

AXGN

60/100

BSX

67/100

Quality

Is it a profitable, well-run business?

AXGN

0.0/10

BSX

5.5/10

Growth

Is the company growing?

AXGN

6.0/10

BSX

6.6/10

Valuation

Is the price reasonable? (higher = cheaper)

AXGN

2.5/10

BSX

9.2/10

Risk

How risky are the shares? (higher = lower risk)

AXGN

2.9/10

BSX

4.9/10

Momentum

Is the share price trending up?

AXGN

6.8/10

BSX

6.0/10

Financial strength

Is the balance sheet healthy?

AXGN

6.7/10

BSX

5.8/10

The balanced view

Model-generated

AxoGen, Inc.

This company scores above average, with supportive analyst views and a positive price trend, although its profitability is thin.

Leads on: momentum, financial strength

Best feature: analysts broadly positive (Target upside: 37.5%)

Watch out: profitability is thin (Return on equity (TTM): -17.9%)

Boston Scientific Corporation

This company scores above average, with a reasonable valuation and solid growth.

Leads on: quality, growth, valuation, risk

Best feature: reasonable valuation (PEG: 0.40)

Watch out: weakest area: risk profile (Largest 1Y drawdown: -60%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.